Randomized trial of embolic agents in balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
Not Applicable
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000015012
- Lead Sponsor
- Gastroenterology & Hepatology, Faculty of Medicine, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 190
Inclusion Criteria
Not provided
Exclusion Criteria
1)Previous history of TACE 2)Severe concomitant disease (excluding chronic liver disease) 3)Receiving sorafenib 4)Developed esophagogastric varices 5)History of severe allergy to platinum complex or iodine contrast material 6)Pregnant or lactating female 7)Patients who are considered to be inappropriate to participate in this study by their physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Therapeutic effect
- Secondary Outcome Measures
Name Time Method Safety